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Abstract
Background: Few genome-scale models of organisms focus on the regulatory networks and none
of them integrates all known levels of regulation. In particular, the regulations involving metabolite
pools are often neglected. However, metabolite pools link the metabolic to the genetic network
through genetic regulations, including those involving effectors of transcription factors or
riboswitches. Consequently, they play pivotal roles in the global organization of the genetic and
metabolic regulatory networks.
Results: We report the manually curated reconstruction of the genetic and metabolic regulatory
networks of the central metabolism of Bacillus subtilis (transcriptional, translational and post-
translational regulations and modulation of enzymatic activities). We provide a systematic graphic
representation of regulations of each metabolic pathway based on the central role of metabolites
in regulation. We show that the complex regulatory network of B. subtilis can be decomposed as
sets of locally regulated modules, which are coordinated by global regulators.
Conclusion:  This work reveals the strong involvement of metabolite pools in the general
regulation of the metabolic network. Breaking the metabolic network down into modules based on
the control of metabolite pools reveals the functional organization of the genetic and metabolic
regulatory networks of B. subtilis.
Background
Recently, the reconstruction and analysis of genome-scale
genetic and metabolic regulatory networks has become an
area of active research. It requires the integration of exist-
ing knowledge as a first step towards systems biology,
which we define as the study of the interactions between
the components of biological systems to understand how
these interactions give rise to the function and behavior of
Published: 26 February 2008
BMC Systems Biology 2008, 2:20 doi:10.1186/1752-0509-2-20
Received: 25 October 2007
Accepted: 26 February 2008
This article is available from: http://www.biomedcentral.com/1752-0509/2/20
© 2008 Goelzer et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
Page 2 of 18
(page number not for citation purposes)
the system. Genetic and metabolic networks have been
constructed for Helicobacter pylori [1], Haemophilus influen-
zae [2], Lactococcus lactis [3], Escherichia coli [4], and Homo
sapiens [5], by incorporating the description of chemical
reactions into a stoichiometric matrix. Transcriptional reg-
ulation by regulatory proteins has been included in the
last update of the model of Saccharomyces cerevisiae [6,7].
However, most of these models do not explicitly include
regulation mediated by metabolites, with the exception of
the most recent version of the EcoCyc database [8].
Metabolites can modulate the activity of transcription fac-
tors and enzymes and are therefore key regulators.
Reconstruction of the metabolic network and its associ-
ated regulatory network contributes to resolving various
problems such as unravelling how the bacterium coordi-
nates its genetic and metabolic networks to adapt to envi-
ronmental changes [9,10] and elucidating the global
organization of the regulatory network [11,12]. Such
work will also help develop tools and concepts to handle
and to analyze the inherent complexity of biological func-
tions. As this represents one of the central issues of the sys-
tems biology approach, metabolic networks have been the
focus of in depth studies [13,14], and various tools have
been developed to unravel the organization of these
highly complex networks [15,16].
Here, we report the reconstruction of the genetic and met-
abolic regulatory network for the Gram-positive bacte-
rium Bacillus subtilis. B. subtilis has been studied for over
40 years and is one of the best-characterized bacteria, eas-
ily amenable to genetic and physiological studies. The
publication of the B. subtilis genome sequence [17] and
subsequent international programmes of systematic gene
disruption, functional analysis and regulatory network
studies [18], makes this microorganism a prime candidate
to develop systems biology. Our model includes the bio-
chemical reactions of the metabolic network and all the
known levels of regulation involved in metabolic path-
ways: transcriptional, translational, post-translational and
modulation of enzymatic activities. To obtain the most
complete view of the interplay between the metabolic net-
work and genetic regulation, the description of each regu-
latory mechanism includes known roles of metabolite
concentrations, ions, and any other quantities related to
the state of the metabolic network. The entire model
(reactions, enzymes, genes and regulations) has been
curated manually, using published data and expert knowl-
edge.
Using this model, we were able to examine various aspects
of the general organization of metabolic regulation. We
find that metabolite pools are strongly involved in regula-
tion of the central metabolism of Bacillus subtilis, in agree-
ment with the findings from an analysis of the genetic
regulatory network of Escherichia coli [19]. Moreover, by
introducing the notion of local and global regulation, we
reveal that the complex regulatory network can be broken
down into sets of locally regulated modules, which are
coordinated by global regulators. Local regulations ensure
that the control of elementary pathways through genetic
and/or enzymatic regulation depends upon the level of
key metabolites. The regulation of tryptophan synthesis
by tryptophan through the TRAP regulatory protein is an
example of such a local regulation. In contrast, global reg-
ulations ensure the coordination between these elemen-
tary pathways in response to environmental changes. For
example, CcpA inhibits several pathways during glycolytic
growth conditions. The integration of these local/global
levels and the use of the classification of sensing signals in
[19] lead to recover the main physiological aspects of
metabolism of Bacillus subtilis. Finally, the notion of local
and global regulation allows the graphic representation of
any metabolic pathway and its various regulatory mecha-
nisms.
Results
Model construction
Our aim was to study the general organization of the met-
abolic functions of B. subtilis, to identify the components
involved in their regulations and to unravel how these reg-
ulations coordinate metabolism (involving various degra-
dative and biosynthesis pathways of anabolism and
catabolism). Pathways involved in the metabolic func-
tions can be classified as "minor" or "major" according to
the flux through the pathway. Typically, the "major" met-
abolic pathways are those involved in the production of
energy, redox power, and metabolic precursors of pro-
teins, RNA, DNA, membrane and cell wall. The "minor"
metabolic pathways include the de novo synthesis of cofac-
tors and secondary metabolites (including vitamins, coen-
zymes, and antibiotics). Most minor metabolic pathways
are linear and poorly connected with other pathways,
whereas major metabolic pathways are highly intercon-
nected with other pathways, implying coordinated regula-
tory mechanisms. We focused on the major metabolic
pathways of B. subtilis, and in particular: central carbon
metabolism; aerobic and anaerobic respiration; fermenta-
tion; and amino acids, nucleotides and fatty-acids metab-
olism. We have not included the synthesis of precursors of
cell wall components, such as peptidoglycan. The regula-
tions of these pathways are poorly characterized, and not
coupled with most of the major metabolic pathways.
The model was built from the reconstruction of these
main metabolic pathways (see Methods). It corresponds
to a so-called knowledge-based model describing the
chemical reactions, known transcriptional, translational
and post-translational regulations and controls of enzy-
matic activities. In contrast to classic representations ofBMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
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genetic regulatory networks that integrate only regulation
by transcription factors [7], we have also incorporated
transcriptional regulations by premature termination of
transcription. The translational and post-translational reg-
ulations correspond to regulation (i) by sequestration of
the Ribosome Binding Sequence (RBS); (ii) by small non-
coding RNA; (iii) by sequestration of proteins and (iv) by
proteolysis. We also systematically included (i) a descrip-
tion of enzymatic complexes, which are represented as a
sum of genes, (ii) genetic organization in operons, and
(iii) the number of promoters for each gene and the
detailed conditions of transcription from each promoter
(see Methods). The final model includes 534 genes, 563
reactions, 65 transcription factors (TF), 9 sigma factors
and 21 other mechanisms of genetic regulation at the
transcriptional or translational level (see Table 1). The
model also includes 95 different genetic regulations
involving either transcription factors (and sigma factors)
or other mechanisms. This model provides a basis for
future developments of dynamic models.
An essential aspect of this work is the manual curation of
the information. We integrated the enzymatic reactions
and all the regulation mechanisms which have been
experimentally validated. The key literature references for
each reaction and each regulation described are included
in the model. Nevertheless, in a few instances, concerning
fermentation and degradation of branched-chain amino
acids (BCAA), the existence of a functional pathway is
based on indirect evidence rather than on a detailed study;
these pathways are annotated with a comment indicating
that the level of knowledge is low. The complete set of
data (see Additional file 1) and a review of the available
information on B. subtilis (see Additional file 2 and 3) are
presented in Additional files.
Comparison of our model with published phenotypes
Because our model integrates information that has been
confirmed by experiments with the exception of fermen-
tation and degradation of branched-chain amino acids, its
validation and its biological relevance are intrinsic. How-
ever, it is interesting to assess whether our model recovers
known phenotypes of B. subtilis mutants [18,20,21]. In
particular, the effects of genetic regulations on prediction
of the phenotypes of gene deletion can be evaluated.
Using the methodology described in Methods, we have
predicted whether a gene deletion is lethal or viable in two
different growth conditions: a poor and a rich medium
corresponding to a M9 glucose minimal medium and a LB
medium, respectively (see Additional file 1 and Addi-
tional file 4 for their exact composition). Compared to the
results obtained in [20], the introduction of genetic regu-
lations in this analysis allowed the prediction of pheno-
types associated to the deletion of genes encoding
transcription factors (requirement of gltC, cysL, rtpA in
minimal medium) and the recovery of so-called complex
phenotypes resulting from the dysfunction of transcrip-
tional regulation. One such example is the absence of
growth of an hprT mutant on LB medium [18]. The hprT
gene encodes the hypoxanthine-guanine phosphoribosyl-
transferase, which converts hypoxanthine and guanine in
IMP and GMP, respectively (see Additional file 5, Figure
S47), and avoids de novo synthesis of purines. Hypoxan-
thine and guanine are indeed the effectors of the G-box
riboswitch [22] which inhibits the transcription of genes
involved in de novo purine synthesis. In LB medium, the
hprT mutant may accumulate hypoxanthine and guanine,
which in turn may prevent the transcription of the pur
operon via the G-box riboswitch. The absence of GMP
synthesis would then prevent the growth of the hprT
mutant even in LB medium. Of course, this prediction
remains to be tested experimentally.
Focus on the isoenzymes
Isoenzymes may be required in different physiological
conditions or in different metabolic pathways, and their
synthesis may be differentially regulated. To address this
issue, we summarized in Additional file 6 all characterized
isoenzymes in B. subtilis and their regulations. The regula-
tion of synthesis and/or enzymatic activities is known for
56 of the 80 isoenzymes characterized. Most of these 56
isoenzymes fall into two categories: (i) they are active in
different physiological conditions (vegetative growth,
sporulation, etc.); (ii) they are involved in distinct meta-
Table 1: Integration of information
Genes 534 organization in 186 operons
Metabolites 456
Reactions 563 metabolic pathways, complexes, enzymatic regulation
Enzymatic regulations 79 including cofactors, ions and regulations by metabolites
Genetic regulations 65 TFs 9 Sigma factors 21 others* with their metabolite effectors, distinction between activation and modulation
Functions 7 - central carbon pathway, overflow
- fermentation, oxidative phosphorylation,
- carbohydrate transport and degradation,
- amino acid synthesis and degradation
- nucleotide synthesis and salvage pathways
- fatty-acid synthesis and degradation
*correspond to RtpA, S-box, L-box, A-box, G-box, Plead, SR1 and 14 T-boxes.BMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
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bolic pathways with the existence of differential enzy-
matic and/or transcriptional regulations. Two detailed
examples that typify these two different categories are
illustrated.
The asparagine synthases encoded by the asnO, asnB and
asnH genes are an example of the first category of isoen-
zymes. In a rich sporulation medium, asnB is expressed
only during exponential growth. asnH  transcription
increases during the transition between exponential
growth and stationary phase while asnO is expressed only
later in sporulation. In a minimal medium, both asnB and
asnH  are expressed constitutively during exponential
growth and in stationary phase, but the expression of
asnO is not detected in either phase [23]. The mechanism
of regulation of asnB expression is still unknown whereas
asnH belongs to the CodY regulon [24]. The release of
CodY repression during the transition between exponen-
tial growth and stationary phase is responsible for the
derepression of asnH transcription. The asnO gene is tran-
scribed from a σE-specific promoter, which explains its
induction only during sporulation.
The second category can be illustrated with the car-
bamoyl-phosphate-transferase. This two-subunit enzyme
produces carbamoyl-P from CO2, glutamine and ATP. The
carbamoyl-phosphate-transferase is involved in two path-
ways: arginine biosynthesis and pyrimidine synthesis. In
B. subtilis, this enzyme is encoded by two sets of genes:
carA and carB, or pyrAA and pyrAB. carA and carB belong
to an operon with other genes involved in arginine syn-
thesis. The expression of this operon is repressed by AhrC
using arginine as corepressor [25]. pyrAA  and  pyrAB
belong to the pyrimidine operon, which is regulated by
PyrR in response to the availability of metabolites of the
pathway (UMP, UTP and PRPP) [26]. Each enzyme
belongs to a different pathway, and is synthesized under
particular physiological conditions thereby avoiding func-
tional redundancy. By contrast, only the carAB operon is
present in E. coli. This operon is transcribed from two pro-
moters, one controlled by arginine through the transcrip-
tion factor ArgR, and the second controlled by
pyrimidine. In addition, the enzyme is activated by orni-
thine and IMP, and inhibited by UMP [27]. These two
organisms have developed different regulatory solutions
to achieve the same goal: the production of carbamoyl-P
for the syntheses of arginine and pyrimidine.
Few isoenzymes appear to be controlled by the same reg-
ulation (see Additional file 6). The pairs of amino-acyl
tRNA synthetases (tyrS/tyrZ, thrS/thrZ) both seem to be
transcribed under the control of T-boxes specific for tyro-
sine or threonine, but are active in different physiological
conditions [28,29]. Thus, they could belong to the first
category. Other isoenzymes are known to be regulated in
the same way and synthesized in the same physiological
conditions: (i) the OAS thiol-lyases (cysK, mccA) [30], (ii)
the cysteine desulfydrases (cysK, mccB) [31], (iii) enzymes
involved in fatty acid metabolism (the α-keto-acyl syn-
thase, acyl-CoA dehydrogenase, and 3-hydroxyacyl-CoA
dehydrogenase/enoyl-CoA hydratase complex) [32-34,9].
These isoenzymes can catalyze different chemical reac-
tions in vitro and present different and complementary
activities with respect to their substrates.
Structure of the genetic regulatory network: key role of 
metabolic pools in general control
Our model allows a detailed analysis of the interplay
between metabolic pathways and genetic regulation
through a large set of metabolic pools (and others effec-
tors). Among the 79 genetic regulators whose effector is
known, 70% (59) have a metabolite as effector (see Table
2). Furthermore, eight additional regulators respond to an
ion or to a component of the PTS, and are thus strongly
coupled to the metabolic network as they are linked to the
availability of particular glycolic sugars through a compo-
nent of the PTS. The remaining 13 genetic regulators have
no effectors: 4 genetic regulators, AbrB, RtpA, YtlI and SR1,
which are all under the control of other(s) genetic regula-
tor(s) (resp. Spo0A, T-box and Plead, CymR and Spx,
CcpN and CcpA), and nine sigma factors. The effectors for
15 genetic regulators are still unknown. However, indirect
evidences from the literature suggest that at least eight of
these may respond to a metabolite effector, because they
are part of two-component systems (YycF, ResD), are
involved in carbohydrate catabolism (YtrA, FruR, RbsR) or
regulate the synthesis of specific enzymes in response to
the nutrient availability (CysL, CcpN, GlnR). The remain-
Table 2: Classification of genetic regulators according the nature of their effectors
Genetic regulators TFs Sigma factors Others Total
Metabolic effector 40 0 19 59
Effector related to metabolism (ion, PTS component) 8 0 0 8
No effector 2 9 2 13
Putative metabolic effector 8 0 0 8
Unknown effector 7 0 0 7
Total 65 9 21 95BMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
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ing genetic regulators are ArfM, Spo0A, SpoVT, SpoIIID,
GerE, CcpB and Spx.
Essential role of metabolites in genetic regulations
The interplay between the metabolic pathways and the
genetic regulations is very strong: at least 13% of 456
metabolites are involved in genetic regulation and 53% of
the genes involved in metabolic pathways are directly reg-
ulated by a genetic regulator under the control of a metab-
olite. Metabolites are also strongly involved in the control
of enzymatic activities. Thus, metabolites are key actors in
the general regulation of metabolic pathways through
these two levels of regulation (genetic and enzymatic).
Each metabolic pathway of B. subtilis for which the regu-
lation is known, is under the direct control of a metabolite
through a genetic or an enzymatic regulation (see Addi-
tional file 1): at least one gene (resp. one enzyme) of each
pathway is controlled by a metabolite through a genetic
(resp. enzymatic) regulation.
Hierarchical organization of the genetic regulatory network
We analyzed the hierarchical organization of the genetic
regulatory network [35,36] by examining the cascade of
regulations induced by each genetic regulator (GR). A GR
of level 1 does not regulate other GRs. A GR will be on
level n if the highest level of the GRs that it regulates is (n
- 1). In E. coli, only 23 GRs are on level 3 or higher, and
only two are level 5 (belong to the highest level) [36].
The hierarchical organization of the genetic regulatory
network of B. subtilis is presented in Figure 1. This genetic
regulatory network includes not only transcription regula-
tors, but also mechanisms of control by premature termi-
nation of transcription (T-box, G-box, A-box, L-box, S-
box) and translational regulations by small regulatory
RNAs (SR1) and by peptide leaders (Plead). Sigma factors
have not been included in Figure 1. Five levels of regula-
tion were found in this analysis of the major metabolic
pathways of B. subtilis.
CcpA and YycF are the regulators of the highest level in the
genetic regulatory network (level 5). YycF is indirectly
involved in the regulation of metabolic pathways (respira-
tion and fermentation) via a cascade of regulations
involving PhoP, ResD, FNR and ArfM. CcpA, which man-
ages carbon uptake and catabolism, is connected to the
PhoP, ResD, Fnr and ArfM cascade. 17% of genetic regula-
tors are under the direct control of CcpA. Other known
pleiotropic regulators, like DegU and Spo0A, are at level 2
or 3. Their observed level will presumably increase as
genetic networks involved in other biological processes,
such as sporulation or competence, are added to the
model. However, DegU and Spo0A clearly modulate few
different enzymes and they do not seem to make a large
contribution to the direct regulation of metabolic path-
ways. This suggests a partial decoupling between the con-
trol of metabolic pathways and other biological processes.
Metabolic pathways are mainly under the global control
of CcpA, CodY and TnrA. Other pleiotropic transcription
factors (DegU, Spo0A, AbrB) only modulate the expres-
sion of very few specific enzymes which seem to be mainly
involved in other biological processes. For example, CitB
is required during sporulation [37] and its synthesis is
controlled by CodY and AbrB [38].
Identification of functional elementary modules through local and 
global regulations
All the genetic regulators of level 1 and some of level 2 reg-
ulate a specific pathway and their potential metabolite
effectors belong to the controlled pathway (see Additional
file 1). This control of a pathway as a function of the pool
of effector metabolite was termed "local regulation". In
turn, the set of enzymes associated with a local regulation
and the local regulators define a functional "elementary
module" (see details in the Discussion). For example, the
enzymes TrpE, TrpG, TrpD, TrpF TrpC, TrpA, TrpB
involved in the tryptophan synthesis together with the
regulators TRAP, RtpA, the tryptophan-specific T-box and
the tryptophan-rich peptide leader Plead define an ele-
mentary module (see Additional file 5, Figure S26).
Indeed the enzymatic complex TrpE+TrpG is regulated by
TRAP at the genetic level, and by tryptophan at the enzy-
matic level. This elementary module definition is based
on the mathematical developments given in Additional
file 7, which describes the key control properties associ-
ated to local regulations (according to our definition).
Elementary modules have been manually identified dur-
ing the curated reconstruction of the genetic and meta-
bolic network of B. subtilis by a strict application of the
local regulation definition. Global regulators of a meta-
bolic pathway are defined as any non-local regulators
involved in the control of this pathway. The set of global
regulators in the metabolic network is composed by all
the genetic regulators that have been identified at least
once as global regulators of a metabolic pathway. They
mainly correspond to level 2 to 5 regulators. Additional
file 8 presents the local/global classification of all genetic
regulators of the reconstructed regulatory network. We
have previously identified CcpA, TnrA and CodY as the
three most important regulators involved in the control of
metabolic pathways, and the analysis of their local or glo-
bal roles in regulation is summarized.
CcpA  is the main regulator responsible for catabolite
repression in B. subtilis, thus managing the carbon
resources [39]. Fructose-1,6-biphosphate (FBP) is consid-
ered to be the main metabolite effector of CcpA. Although
CcpA binds to DNA as a complex with HPr-Ser46-P, FBP
is required both for the phosphorylation of HPr by the
HPr kinase and for the formation of the CcpA/HPr-Ser46-BMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
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P complex [40,41]. CcpA directly regulates carbohydrates,
fatty-acids and amino acids degradation (see Additional
file 6, Table S3 for details). As FBP is not an intermediate
metabolite in these pathways, CcpA is a global regulator
for these pathways.
TnrA is the main regulator involved in nitrogen manage-
ment [42]. In excess of glutamine, glutamine binds to the
glutamine synthase GlnA. This feedback-inhibited
glutamine synthase sequestrates TnrA [43], so glutamine
can be considered as the metabolite effector of TnrA. TnrA
acts on various metabolic pathways, including asparagine
and purine degradation [44,45] leading to NH3 produc-
tion, where glutamine is not directly involved. Therefore,
TnrA belongs to the set of global regulators.
CodY  acts on various metabolic pathways, including
BCAA synthesis, and histidine and asparagine degrada-
tion leading to glutamate production. CodY, which is also
involved in the control of competence, mobility and
sporulation [24], is a global regulator. However, CodY can
be considered as a local regulator for BCAA synthesis.
Indeed, GTP and branched-chain amino-acids are the sig-
naling molecules sensed by CodY [46], but as the GTP
effect on CodY-dependent regulation of BCAA synthesis is
weak [47], BCAA can be considered as the main metabo-
lite effector for CodY in this pathway.
Among the other global regulators with less important
roles in the general control of metabolic pathways (see
Additional file 8 and previous paragraph), two subsets can
be distinguished. The first subset is composed of global
regulators (i) managing the metabolic function according
to the depletion of a critical resource, for example phos-
phate availability through the two-component system
PhoPR [48], and (ii) adapting the metabolic network to
increase/decrease the production of some metabolites, for
example the stimulation of the conversion of cysteine
from methionine by Spx when methionine is the sole sul-
phur source [49]. Clearly, the two global regulators cho-
sen as examples are under the control of specific signals,
although that sensed by Spx remains un-characterized.
The second subset corresponds to global regulators
involved in the control of complex biological processes
such as sporulation (SpoIIID, SpoVT, Spo0A) and the
transition from exponential to stationary phase (AbrB and
DegU).
Remark on the identification of functional elementary modules
In some cases, the identification of elementary modules is
controversial, because (i) it does not correspond to a clas-
sical metabolic pathway (e.g. glycine synthesis); (ii) isoen-
zymes often belong to different elementary modules (e.g.
asparagine and proline syntheses); (iii) local regulators in
an elementary module can also correspond to global reg-
ulators for other modules (e.g. CodY). Three examples of
these ambiguities – glycine, proline and branched-chain
amino acid syntheses – are presented below. Glycine is
synthesized in one step from serine by GlyA (see Addi-
tional file 5, Figure S13). The expression of glyA  is
Hierarchical architecture of the genetic regulatory network Figure 1
Hierarchical architecture of the genetic regulatory network. Each ellipse refers to a mechanism of transcriptional regulation, 
including: (i) transcription factors; (ii) early termination of transcription (T-box, L-box, G-box, A-box, S-box, TRAP); (iii) pro-
teins involved in transcriptional regulation (RtpA). Each hexagon refers to a mechanism of translational regulation, including: (i) 
small RNA (SR1); (ii) peptide leaders (Plead). The arrow indicates the causality of the regulation. A regulator with a curved 
black arc indicates that it is subject to auto-regulation. Blue, magenta and dark red regulators have a metabolite, a PTS compo-
nent, and an ion, respectively, as effector. The effector of brown regulators is unknown. Black regulators have no effector.
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repressed by PurR, the global regulator involved in purine
synthesis [50]. Glycine is also required in purine synthesis
(see Additional file 5, Figure S43). As a consequence, GlyA
belongs to the purine synthesis module, and is not an
autonomous module.
The main difficulty for module identification in proline
synthesis (see Additional file 5, Figure S23) is the presence
of isoenzymes (ProB/ProJ and ProG/ProH/ProI). There
are two different modules: one (proA, proB and proI) is
probably controlled by the proline specific T-boxes
located upstream from proI and proBA, and is required in
anabolism; the second (proJ and proH) is induced during
osmotic stress. The regulation of the remaining isoenzyme
ProG is unknown, so it is difficult to assign it to these or a
third module.
The branched-chain amino acid synthesis (see Additional
file 5, Figure S15) is controlled by CcpA, CodY, TnrA [51]
and a leucine-specific T-box [52]. CcpA and TnrA are two
global regulators while the T-box-dependent control is a
local regulation. Despite its global regulatory role, CodY,
as explained previously, is a local regulator for this path-
way.
A graphic representation of metabolic pathways and their 
associated regulations
We have developed a graphic representation of metabolic
and genetic regulatory networks, which allows the visual-
ization of different levels of regulation (transcriptional,
translational, protein-protein interactions, enzymatic
control). A graphic representation for each metabolic
pathway is available in Additional file 5. The graph pro-
vides a view of metabolic pathways with the key regula-
tory players represented (Figure 2). The steps of a
metabolic pathway catalyzed by enzymes whose regula-
tions are unknown are not detailed. The graph also dis-
plays the metabolite pools, which are (i) precursors for
the pathway, (ii) nodes of control, and (iii) involved in
regulations through premature termination of transcrip-
tion, transcriptional factors or enzymatic controls. The
formalism used for the representation of pools of metab-
olites, enzymes and transcription factors is described in
the legend of Figure 2. By convention, the level of the
metabolite pools that are involved in regulations is high,
and the level of the enzymes and transcription factors
pools depends on their genetic regulations. The represen-
tation simplifies a complex genetic regulation (available
in detail in Additional file 1) in a Boolean condition
Graphic representation of the synthesis of tyrosine from chorismate Figure 2
Graphic representation of the synthesis of tyrosine from chorismate. Yellow (resp. pink, green) boxes correspond to metabo-
lites (resp. enzymes, transcription factors) pools. The black (resp. orange) arrows correspond to transcriptional/translational 
(resp. enzymatic) regulations. The effect of the regulation is indicated by the sign "-" in the case of a repression/inhibition, or by 
the sign "+" in the case of an induction/stimulation. A closed purple circle, associated with an enzyme, means that the gene(s) 
encoding the corresponding enzyme may be constitutively transcribed. An ellipse corresponds to a transcriptional regulator 
(transcription factor, T-box) that can be "on" (in green) or "off" (in red). The state "on" is defined as "able to bind to DNA". A 
hexagon represents a translational regulator that could also be "on" (in green) or "off" (in red). The translational regulator is 
defined as "on" when it is able to bind to mRNA.
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between the players (a metabolite effector, a sequestrated
protein) involved in the regulation.
To illustrate exploitation of this representation, we used
the biosynthesis of tyrosine from chorismate as an exam-
ple because it combines all the types of control (Figure 2).
The pathway is subject to diverse types of regulation: (i)
enzymatic control, (ii) transcriptional and translational
regulation involving the TRAP repressor, (iii) control by
premature termination of transcription at the T-box, and
(iv)protein-protein interactions with the sequestration of
TRAP by RtpA.
Tyrosine is synthesized from chorismate in three steps,
with intermediate production of prephenate. Chorismate
and prephenate are also precursors of other metabolic
pathways (folate and menaquinone synthesis for choris-
mate, and phenylalanine synthesis for prephenate). Pre-
phenate is formed from chorismate by two chorismate
mutases, encoded by the aroA and aroH genes [53]. AroA
is a bi-functional enzyme, with chorismate mutase and 3-
deoxy-D-arabino-heptolosonate-7-phosphate (DAHP)
synthase activity [54]. The synthesis of prephenate from
chorismate is summarized in Figure 2 as
prephenate = chorismate AND (AroA OR AroH).
Chorismate and one of AroA and AroH are necessary to
produce prephenate. There is no information available
concerning the transcription of aroA and aroH. However,
AroA and AroH activities are inhibited by prephenate
[53,54], and AroA activity is also inhibited by chorismate.
The inhibition of AroA by prephenate and chorismate is
represented by two orange arrows that link the prephenate
and chorismate metabolite to the AroA enzyme, with a "-
" sign. The AroH inhibition by prephenate is similarly rep-
resented.
Tyrosine is synthesized from prephenate in two steps by
the sequential action of the prephenate dehydrogenase,
TyrA, and aminotransferases, AroJ and an unknown pro-
tein (defined as X on Figure 2). TyrA activity is feedback-
inhibited by tyrosine [55], and enzymatic control repre-
sented in Figure 2 by the orange arrow that links tyrosine
to TyrA.
aroJ  and  tyrA  belong to the tryptophan operon (trp
operon), transcribed from a σA promoter. The transcrip-
tion of the entire operon is modulated by termination/
antitermination of transcription involving the TRAP pro-
tein. TRAP binds to the nascent mRNA and prevents elon-
gation of transcription. The translation of two genes of the
trp operon (trpE and trpD) is further modulated by TRAP
(see below). tyrA and aroJ are also transcribed from an
internal constitutive σA-dependent promoter [56]. In our
model, the control of tyrA transcription by the two pro-
moters is described thus
The transcriptional regulation of a gene is modelled by a
black arrow, which links the regulator to the enzyme (or
more generally the protein) that the gene encodes. The
direction of the regulation is indicated by the sign "+"
(induction) or "-" (repression). The transcriptional regu-
lator, represented by an ellipse in Figure 2, may act on the
transcription of a gene by any of the known mechanisms:
classical control of the initiation of transcription by regu-
lators and termination/antitermination mechanisms (T-
boxes, S-boxes, G-boxes, etc). By default, the absence of a
black arrow or a purple circle for an enzyme means that
no information is available about the transcription of the
corresponding gene. Several mechanisms can control an
enzyme pool: AroJ is both linked to an arrow (control by
TRAP at the first promoter) and to a purple circle (consti-
tutive transcription of the internal promoter) in Figure 2.
In the presence of tryptophan (TRP), TRAP is active and
binds to the nascent trp-mRNA (state "on"). The anti-
TRAP protein (RtpA) can sequester active TRAP associated
with TRP by protein-protein interactions. The TRAP-RtpA
complex is unable to bind to mRNA, leading to the tran-
scription of the TRAP regulon. The state "on" of TRAP,
which is defined as the conditions that enable the binding
on mRNA, is described by
TRAPon = TRAP AND TRP AND NOT(RtpA).
TRAP also modulates the translation of the trpE and trpD
genes by binding to the complete trp-mRNA. The trpE
ribosome-binding site (RBS) is then sequestrated in a
RNA secondary structure preventing ribosome binding
and trpE translation. The coding sequences of trpE and
trpD overlap by 29 nucleotides thereby coupling the trans-
lation of these two genes. The translation of trpD is also
affected by the binding of TRAP to the trpE RBS [57]. In
our graphic representation, a mechanism of translational
regulation is modelled by a hexagon, which is bound
(state "on") or not (state "off") to the mRNA (Figure 2).
TRAP is represented both by an ellipse for transcriptional
control and by a hexagon for translational control. So, the
repression of TrpE synthesis results in a combination of
transcriptional- and translational-dependent modula-
tions:
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Because the transcription of the mtrB gene encoding TRAP
is constitutive, the free TRAP concentration is correlated
only with the amount of anti-TRAP protein RtpA. rtpA
transcription is regulated by a tryptophan-specific T-box,
and its translation is modulated by the translation of a
peptide leader RtpLP, located upstream from the rtpA
gene. Three codons for tryptophan are present in the CDS
of RtpLP. Complete translation of RtpLP prevents the
translation of RtpA (for a review on TRAP regulation see
[57]). The regulation of the translation of rtpA-mRNA by
the peptide leader (Plead) is represented in Figure 2 by a
hexagon, because it corresponds to a translational regula-
tion. An "off" state for translational regulation is defined
as the conditions that prevent the translation of the
mRNA. In our example, the "off" state of the peptide
leader corresponds to the presence of tryptophan:
Pleadoff = TRP
Finally, the activity of the anthranilate synthase
(TrpE+TrpG), which catalyzes the first step of synthesis of
tryptophan from chorismate, is also inhibited by tryp-
tophan [55].
In conclusion, the synthesis of tryptophan, which pro-
ceeds in several steps from chorismate, is simplified and
reduced to one step in the graph of the tyrosine synthesis
pathway (Figure 2). The major points of regulation are
indicated: (i) inhibition of the anthranilate synthase by
tryptophan; (ii) TRAP-dependent modulation of the tran-
scription of all the genes involved in the synthesis of tryp-
tophan; (iii) TRAP-dependent modulation of the
translation of trpE and trpD; (iv) TRAP sequestration by
RtpA; and (v) conditions of transcription and translation
of RtpA.
The graphic representation of tyrosine synthesis displays
the main players involved in the regulation of this path-
way (TRAP, prephenate, chorismate, tyrosine and tryp-
tophan) and whether their action is enzymatic,
transcriptional or translational.
Discussion
General organization of the regulatory network
We investigated the general organization of the B. subtilis
metabolic pathways and searched for possible rules of reg-
ulations. The organization emerges when all the levels of
regulations involved in a particular metabolic pathway are
taken together. Two levels of regulation appear clearly (see
Figure 3): one local and one global. The local regulation
corresponds to any type of regulation (transcriptional,
translational, termination/antitermination, inhibition/
activation of enzymatic activity) which involves a metab-
olite of the pathway controlled. This specific metabolite
will be refered to as the "key metabolite". Local regulation
guarantees the activation or the inhibition of a pathway as
a function of the pool of key metabolite(s) (see proposi-
tion 2 in Additional file 7). The notion of local regulation
allows identification of functional elementary modules in
the metabolic network.
Global regulation of a specific metabolic pathway is
defined as a complementary set of the local regulation.
Remarkably, we notice that our global regulation coin-
cides with global regulation defined by biologists [10,58],
which strengthens the relevance of the defined regulation
levels.
From local and global regulation to the emergence of 
functional elementary modules
As pointed out by several authors [59,60], no consensus
on the definition of a regulatory module exists. Here, we
propose a definition for the metabolic network based on
the in vivo behaviour of regulations through metabolites:
a functional "elementary module" corresponds to (i) a set
of enzymes, which are either regulated by a local regula-
tion, or constitutive (without direct local regulations) and
located in the pathway between the key metabolite and
the first locally controlled enzyme and (ii) the associated
local regulator(s). This definition combines both the
genetic and the metabolic levels through the feedback of
metabolites on enzymes and genes via enzymatic regula-
tions and effectors of genetic regulators, while other defi-
nitions of module are based solely on the genetic level
and clustering [59-61].
The identification of the functional elementary modules
(see Results) allows analysis of the impact of the local reg-
ulators on modules.
Local regulation for the induction/repression of functional elementary 
modules
Two classes of local regulation can be observed in the met-
abolic network of B. subtilis. In the first class, the metabo-
lite effector is the end-product of the pathway; this is the
case for almost all amino-acids biosyntheses. The local
regulator induces enzymes synthesis of the pathway when
the concentration of its effector decreases. In the second
and more frequent class, the metabolite effector is an
intermediate metabolite of the pathway like, for example
the PRPP, which induces purine biosynthesis by prevent-
ing the binding of the repressor PurR to DNA [62]. Regu-
lation of this type is mostly found in degradative
pathways only induced if the first substrate is available, in
the central carbon pathways with CggR in glycolysis [63]
and CcpC in the TCA cycle [64], and in fatty-acids biosyn-
thesis with FapR [65]. The local regulator of this class
induces enzymes synthesis when the concentration of its
effector (the first or an intermediate metabolite) increases.
In both cases, the local regulation causes an increase of theBMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
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metabolic flux through the pathway upstream (for the
first class) or downstream (for the second class) the
metabolite effector (see proposition 2 and 4 Additional
file 7). This allows a qualitative prediction of the modula-
tion of the various quantities attached to the elementary
module (abundance of mRNA, enzyme activities, and
fluxes) in response to changes of the concentration of
metabolite effectors. To summarize, the local regulations
lead to the emergence of functional elementary modules
which can adapt the pathway capability according to the
physiological needs of the cell and to the availability of
precursor metabolites.
Global regulators for the general coordination of functional 
elementary modules
The global regulators, defined as non local regulators, are
listed in Additional file 8; this group contains the well-
known "pleiotropic" regulators [66,10,58]. Two main
effects of global regulators on a module can be found: (i)
turn on/off a module, (ii) modify/modulate the link
between the metabolite effector of the local regulator and
the module induction. The nature of the regulation asso-
ciated with global regulators is summarized in Additional
file 8.
Turn on/off effect
The effect of a genetic regulation is often simplified to an
on/off view of the pathway induction in the modelling
process [67]. In these conditions, the laws of pathway
induction can be described by Boolean logic conditions,
which are easy to manipulate and to simulate [68].
Although this description is often approximate, some glo-
bal regulators clearly belong to this category. Such global
regulation behaviour is often associated with a direct
effect of the global regulator on local regulation (see Fig-
ure 3). In all these cases, the role of this kind of global reg-
ulator is to shape or reshape the metabolic network by
allowing the induction of new elementary modules. How-
Global and local regulation of a metabolic pathway Figure 3
Global and local regulation of a metabolic pathway. Yellow (resp. pink) boxes represent metabolite (resp. enzyme) pools. The 
transcription factors are represented by ellipses. Green and red indicate that the transcription factor is "on" and "off", respec-
tively, where "on" means that the transcription factor is able to bind to DNA. The local transcription factor (TF2) is sensitive to 
an intermediate metabolite (Xn), and modulates the synthesis of enzyme(s) involved in the pathway. The global regulator TF1, 
sensitive to another signal, can modulate (i) the synthesis of intermediate enzymes; (ii) the synthesis of the local transcription 
factor TF2, or (iii) both.
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ever, the induction of a particular module usually remains
under the control of its own local regulator. For example,
the expression of the iol operon (involved in myo-inositol
catabolism) is completely abolished by CcpA in the pres-
ence of glucose plus inositol, while in the presence of
inositol alone, the local regulator IolR is required for its
induction [69].
Modify/modulate local regulation rule
In this second category, a global regulator acts on an ele-
mentary module in a concerted fashion with the local reg-
ulator. The global regulator can modulate the local
regulation by (i) binding directly to DNA, (ii) disturbing
the local regulator binding. The aim of the global regula-
tion is to modify the effect of the variation of the metabo-
lite effector concentration of the local regulator on the
module synthesis. The modulation of arginine degrada-
tion by CcpA through the control of σL  production
belongs to the second category, illustrating that these cat-
egories are not exclusive. Arginine can be used as sole
nitrogen source when glucose is used as the carbon source
[70]. The genes involved in the arginine degradation are
transcribed from a σL-dependent promoter, and induced
by RocR in the presence of ornithine or citrulline [71], and
AhrC in the presence of arginine [25]. CcpA, which inhib-
its the transcription of sigL, indirectly represses arginine
degradation [72]. A B. subtilis sigL mutant cannot use
arginine or ornithine as sole nitrogen source [73], so the
σL concentration must be low but sufficient to allow
arginine degradation in the presence of glucose.
The nature (turn on/off or modulation) of a global regu-
lation in a metabolic pathway allows to build hypotheses
on its physiological role, and to make predictions on the
involvement of the pathway in the general organization of
the metabolic function. For arginine degradation, the
presence of CcpA-dependent regulation suggests that
arginine or ornithine can also be used as sole carbon
source. This study can be extended to all the metabolic
pathways. In particular we can analyze the uptake and
degradation of the different amino acids and predict if
they can be used as carbon or nitrogen sources and also
identify those that might have a "special" status with
respect to the metabolic function (see Additional file 4).
From functional elementary modules to signaling 
pathways
Since the genetic and metabolic regulatory network is
mainly modulated by metabolites, we can focus on the
status of these key compounds for the cell to link our ele-
mentary modules to cell physiology and environmental
conditions. We applied and extended the internal/exter-
nal/hybrid classification of sensing metabolites intro-
duced by Martínez-Antonio and coauthors in [19] for
transcription factors only to all kind of genetic regulators
of B. subtilis considered in this study (T-boxes, etc.; see
Additional file 8). A transcription factor is classified as
"external" when the sensed signaling molecules is local-
ized outside the cell, and "internal" when the sensed sig-
nal is an intracellular or endogenous molecule. A
transcription factor classified as "hybride" senses a partic-
ular metabolite that, depending on growth conditions, is
either synthetized in the cell or transported from outside.
Hybrid local regulators repress modules involved in anab-
olism while they activate modules involved in catabolism.
External local regulators activate modules involved in the
management of gluconeogenic carbon sources. Internal
local regulators are involved both in anabolism and in
catabolism. Those involved in carbohydrates catabolism
activate their corresponding modules and have the same
physiological role as hybrid local regulators. The remain-
ing internal local regulators seem to be involved in anab-
olism and in the central carbon management.
Global regulators sense internal metabolite pool with the
exception of CodY, which senses both internal and hybrid
signals. Internal global regulators are mainly involved in
catabolism as indicated in Results and in Additional file 8.
Since an internal global regulator controls various mod-
ules, its metabolic effector should presumably be corre-
lated to a physiological state, and allow the cell to take
global decisions. The concentration of the CcpA effector
FBP is correlated with the availability of glycolytic carbon
sources [74] and indirectly manages the catabolite repres-
sion through CcpA. The glutamine concentration, sensed
by TnrA, corresponds to the availability of a good ammo-
nium source [42]. TnrA regulates the utilization of sec-
ondary nitrogen sources. Branched-chain amino acids,
sensed by CodY, may reflect the availability of amino
acids in the medium while GTP is strongly involved in
ribosomes synthesis [75], sporulation and the so-called
"stringent response" mechanism [76]. Moreover, the
involvement of the three main global regulators (CcpA,
TnrA, CodY) in the control of branched-chain amino
acids synthesis reveals the putative critical role of these
amino acids in the general management of the cell.
The decomposition of the genetic and metabolic regula-
tory networks into functional modules associated to the
nature of the sensed signals reveals how the cell coordi-
nates the metabolic pathways in response to environmen-
tal changes as summarized in Figure 4. The graph
highlights the conditions of activation of genetic regula-
tors, according to both the availability of nutrients in the
medium and the state (low/high) of internal or hybrid
sensing metabolite.
More generally, the metabolic network and its associated
complex regulations are key components of cell physiol-BMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
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Regulation of the genetic network by metabolite pools of the following biological functions (central carbon pathway, redox and  respiration coordination, phosphate starvation, nitrogen gestion, carbohydrates, nucleotide and amino acids metabolism, ribos- ome activity) Figure 4
Regulation of the genetic network by metabolite pools of the following biological functions (central carbon pathway, redox and 
respiration coordination, phosphate starvation, nitrogen gestion, carbohydrates, nucleotide and amino acids metabolism, ribos-
ome activity). SCS refers to secondary carbon source, PCS to primary carbon source, and SNS to secondary nitrogen source. 
The convention for the graphic representation is the same as for Figure 2.
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ogy. However, the metabolic modules have to be included
in more general and complex regulation schemes (see Fig-
ure 4) where specific metabolite pools (like ATP, GTP,
(p)ppGpp, etc.) play a key role in the coordination of the
metabolic function with other essential biological proc-
esses. Perhaps the most interesting examples are the regu-
lation of translation through the GTP pool and the
stringent response [76] controlling both translation [75]
and DNA replication [77] indirectly through the ppGpp
signaling molecule.
Conclusion
We presented the manually curated reconstruction of the
genetic and metabolic regulatory network of the central
metabolism of Bacillus subtilis. By introducing the notion
of local and global regulation, we showed that the meta-
bolic network can be broken down into sets of elementary
functional modules. In addition, we developed a graphic
representation of metabolic pathways based on these
modules. Finally, we demonstrated that the structural
analysis of metabolic network associated with the inter-
nal/external/hybrid classification of sensing genetic regu-
lators could help to explain how the cell coordinates its
metabolic network according to environmental changes.
Basically, the genetic regulation represses the metabolic
pathways involved in anabolism when the resource is
available in the medium. The metabolic pathways
involved in catabolism are induced by the availability of
the resources in the medium only if a preffered resource is
not available. These strategies minimize the cost of pro-
teins production associated to the metabolic function.
Methods
Model reconstruction
There are few automatic tools allowing the reconstruction
of genetic interaction networks and metabolic pathways,
and they mostly build the metabolic network from the
annotation of the genome and known metabolic path-
ways [78]. Manual validation is nevertheless necessary
because of the discrepencies between the state of annota-
tion and published knowledge. No such tools are availa-
ble for the reconstruction of regulatory networks, which
are mainly built from reports in the literature [79] and
organism-specific databases.
The metabolic and genetic network was reconstructed
from KEGG [80], PAREO (a relational database version of
KEGG), SubtiList [81], and data in the literature. The reg-
ulatory networks were reconstructed from data in the lit-
erature, BRENDA for the control of enzymatic activities
[82] and specific databases for Bacillus subtilis: DBTBS [83]
and SPID [84]. SPID is a protein-protein interactions data-
base, and DBTBS covers the transcription factors of B. sub-
tilis and their regulons. However, DBTBS does not contain
the metabolite effectors of transcription factors and some
transcriptional regulation by early termination of tran-
scription such as riboswitches. Therefore, some of the
information can only be obtained from the literature.
The graphic representation of metabolic pathways has
been developed with the DIA software [85].
Description of regulatory networks
We have integrated the metabolic and genetic regulatory
networks through (i) detailed conditions of transcription
and translation of each gene, based on Boolean logic and
modulation; (ii) detailed enzymatic control; (iii) condi-
tions of activation of transcription factors, also based on
Boolean logic. The Additional file 1 contains six layers.
The first describes the organization of genes into operons.
The second presents the abbreviations used both in this
article and in the Excel file. We predicted the phenotypes
of mutants in layer 3. Layer 4 describes the conditions of
transcription of the transcription factors that have been
included, and also the condition of activation of each
transcription factor. A transcription factor is considered as
"activated", when it is able to bind DNA. In layer 5, are
described (i) the kinetic reactions of metabolic pathways;
(ii) the genes (and operons) that encode the enzymes
involved in reactions; (iii) the condition of transcription
and translation of these genes; (iv) the regulation of
enzymes; (v) the references for these regulations. The last
layer contains the references. The description of transcrip-
tional, translational and enzymatic regulations is pre-
sented below, through two examples: the anthranilate
synthase (encoded by trpE and trpG) involved in the tryp-
tophan synthesis, and glutamine phosphoribosylpyro-
phosphate amidotransferase (encoded by purF) involved
in the purine synthesis.
Level of metabolite pools involved in regulation
By convention, the metabolite pools that are involved in
either transcriptional, translational, enzymatic regulation
or in the activation condition of a genetic regulator, are
supposed to be high.
Transcription from a single promoter
A condition of transcription of a gene is associated to a
promoter, through the following formalism based on
Boolean logic and modulation:
{ [ RNAP binding]*modulation } AND (early termina-
tion of transcription)
The sequence between brackets describes the conditions
for RNA polymerase binding. The modulation corre-
sponds to transcription factors that modulate the tran-
scription of a gene, and finally the conditions after the
brackets describe the control by premature termination of
transcription.BMC Systems Biology 2008, 2:20 http://www.biomedcentral.com/1752-0509/2/20
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The purF gene belongs to the pur operon (see Additional
file 5, Figure S43 and S50), which is transcribed from a σA
promoter, and is repressed both by the transcriptional
repressor PurR [86], and by early termination of transcrip-
tion in the presence of guanine (GUA) or hypoxanthine
(HXTH) [22]. The conditions of transcription are thus
{ [σA]*modI(PurR) } AND NOT(GUA OR HXTH)
where modI is an inhibitive modulation (modA indicates
an activating modulation). In this expression, the modu-
lation by PurR occurs when PurR is bound to DNA. PRPP
prevents PurR binding to DNA [62]. PurR is active in the
presence of PRPP, which is described as:
PurRon = PurR AND NOT(PRPP)
There is no known regulation of purF at the translational
level. So, the corresponding column is empty. The gene
purF  encodes glutamine phosphoribosylpyrophosphate
amidotransferase, which is inhibited by AMP, ADP+GMP,
ADP+GDP and GMP+GDP [87]. Enzymatic regulations by
metabolites are described as modulations, like those
involving transcription (modI, modA). When several
metabolites regulate an enzyme activity, they are sepa-
rated by a comma.
modI(AMP, ADP+GMP, ADP+GDP, GMP+GDP)
When a cofactor is required for the enzymatic activity, it is
indicated between brackets. For example, the succinate
dehydrogenase requires two hemeB and [Fe-S] clusters,
and is strongly inhibited by oxaloacetate (OAA), and
weakly by fumarate (FUM), malate (MAL) and ATP. This
regulation is written as
[Fe-S+2 HemeB]*modI(OAA, FUM, MAL, ATP)
Transcription of a gene from several promoters and description of 
complexes
If a gene is transcribed from several promoters, several
conditions of transcription are included:
[condition 1]OR [ condition 2]
A complex, encoded by several genes, is modelled as a
sum of genes
gene1+ gene2+ gene3
For example, the succinate dehydrogenase, encoded by
sdhA, sdhB and sdhC is designated sdhA+sdhB+sdhC in the
gene column. The sdh genes belong to the same operon,
transcribed from a single promoter. Only one condition
of transcription is included when genes that encode a
complex are in operon. By contrast, trpE and trpG that
encode the two subunits of the anthranilate synthase do
not belong to the same operon. trpE belongs to the trp
operon (Op92), and trpG belongs to an operon involved
in folate synthesis (Op98). The trpG  gene is also tran-
scribed from a second constitutive promoter leading to
the production of a monocistronic trpG transcript (indi-
cated as trpG). The operons are also presented as a sum of
operons in this case. Each part of the sum corresponds to
one gene. For the anthranilate synthase:
The conditions of transcription for Op92, Op98, and the
constitutive promoter upstream from trpG, are described
as a sum of conditions
When post-transcriptional regulations occur, they are
indicated and represented as a sum of conditions. The
TRAP protein prevents the translation of both Op92 (trpE)
and Op98 (trpG), and translation from the trpG constitu-
tive promoter always occurs (TRUE condition).
Predictions of gene deletion phenotypes
We used the constraints-based framework with Flux Bal-
ance Analysis (FBA, [88]) to predict effects of gene dele-
tion on metabolism, with the incorporation of the genetic
regulatory constraints proposed in [89] and applied in
[90] on Escherichia coli. We determined, as proposed in
[89] which enzymes are present according to their genetic
regulation, and deduced the corresponding stoichiometry
matrix to further apply FBA. However, slight modifica-
tions were introduced to integrate in the methodology the
notions of: (i) "modulation" in genes transcription; and
(ii) activation of genetic regulators (switch from "off" to
"on") according to the presence of external metabolite
pools.
(i) A gene whose transcription is only modulated by a
transcription factor is considered present for the FBA anal-
ysis. For example, during growth on glucose, both CcpA
and CcpN transcription factors are active. The sucC-sucD
genes are kept for the FBA analysis since CcpA only mod-
ulates their transcription, while the pckA gene is not con-
sidered since CcpN strongly inhibits its transcription (see
Additional file 1). Moreover, a gene whose transcriptional
regulation is unknown is considered to be constitutively
expressed (present) for the FBA analysis.
Op Op trpG 92 98
trpE trpG
N 	  
  +(, )
{}  A N D  N O T ( []  O R  [] ) σσ σ
AA TRAP ()
trpE trpG
	  
  	  
  +
A
 
NOT (NOT OR TRUE) () TRAP
trpE trpG
	 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(ii) The concentration of intracellular metabolite pools
cannot be quantitatively predicted since the model is only
qualitative. A simplified and qualitative description for
the evolution of metabolite effectors has been used,
according to their hybrid/internal/external status [19].
Intracellular metabolite pools can be set to three levels:
high if the metabolite is present in the medium and can
be imported inside the cell (hybrid signal), medium if an
intracellular synthesis flux exists (internal signal), null if
the metabolite cannot be produced. The level of hybrid or
external me-tabolite effectors leads to determine the state
of hybrid or external genetic regulators given in Addi-
tional file 1 and 8, and so the presence of the controlled
gene for the FBA analysis. Genes under the control of
internal genetic regulators are systematically included in
the analysis. Genetic regulators whose synthesis condi-
tions are fulfilled and whose metabolite effectors are
unknown are supposed to be in state "on".
As the model does not cover the complete metabolic net-
work, we only consider for the predictions that all amino
acids, branched-chain fatty-acids, nucleotides and deoxy-
nucleotides are required to fullfil growth requirements.
The prediction of a gene deletion phenotype is deter-
mined in three steps.
1. All genes are first taken into account, except for the one
whose deletion is tested. When a metabolite is present in
the medium, set its maximal uptake flux to a non-zero
value, and to zero otherwise.
2. Run the FBA analysis. Determine the null/medium/
high level of metabolite pools involved in genetic regula-
tions, according to the rules defined previously.
3. Evaluate the transcriptional rule for genes whose tran-
scription condition is given by Boolean conditions (AND/
NOT) and keep or eliminate genes in consequence. If
some genes are eliminated, go back to step 2, else test the
lethality of the phenotype. Only one iteration was suffi-
cient in the case of our reconstructed metabolic network.
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